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ABSTRACT 
The nucleoside 2’-deoxyzebularine (K) was incorporated into the self-complementary 
dodecamer 5’CGTACGKGTACG3’ by solid-phase 2-cyanoethylphosphoramidite chemistry 
using dimethoxytrityl (DMT) as the 5’-hydroxyl protecting group. Standard synthesis cycles 
using trichloroacetic acid and short ammonia treatment (50 ºC for 30 min) were found to be 
the optimal conditions to obtain the desired dodecamer with minimum acid and basic 
degradation of the acid- and base-sensitive 2-pyrimidinone residue. 
The protonation equilibria of the K nucleoside and of the dodecamer at 37 ºC were studied by 
means of spectroscopically monitored titrations. For the K nucleoside, a pKa value of 3.13 ± 
0.09 was obtained. For the dodecamer, four acid-base species were found in the pH range 2 – 
12, with pKa values of 9.60 ± 0.07, 4.46 ± 0.16 and 2.87 ± 0.19. Melting experiments were 
carried out to confirm the proposed acid-base concentration profiles. Finally, kinetics 
experiments were also carried out at several pH values to evaluate the stability of the K 
nucleoside and of the dodecamer. An increased stability was shown by the K nucleoside when 
incorporated into the dodecamer. Multivariate methods based on both hard- and soft-modeling 
were applied for the analysis of spectroscopic data, allowing the estimation of concentration 
profiles and pure spectra.
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INTRODUCTION 
The incorporation of modified bases into oligonucleotides is a useful approach for the study 
of recognition processes between proteins and nucleic acids. These processes take place 
between functional groups of the protein amino acid chains and the nucleobases, and the 
specificity of these interactions depends on the protein’s ability to recognize a characteristic 
nucleic acid sequence. The present paper reports the substitution of 2’-deoxycytidine for 2’-
deoxyzebularine (K), which chemically corresponds to the deletion of the exocyclic amino 
group from cytosine. Both 2’-deoxyzebularine, (1-β-D-deoxyribofuranosyl-1,2-
dihydropyrimidin-2-one) and the corresponding riboside were identified as comparable 
inhibitors of cytidine deaminase (1,2), but only the riboside (zebularine) showed cellular 
cytotoxic against L1210 leukemia cells in vitro and important antitumor activity in L1210 
bearing mice (3). Because of the fluorescent nature of the aglycon, modified oligonucleotides 
where key cytosines have been replaced with 1,2-dihydropyrimidin-2-one have been 
synthesised to explore the role of ribozyme function (4). Additionally, based on the reduced 
stability of the glycosyl bond under mildly acidic conditions (pH 3), this substitution provides 
a useful approach to the generation of apurinic  / apyrimidinic (abasic) sites. The generation 
of abasic sites is a common form of DNA damage (5,6). Contrary to its behavior under acidic 
conditions, based-catalyzed hydrolysis causes degradation of the 1,2-dihydropyrimidin-2-one 
ring leading to the generation of the known mutagen, 1,3-propanedialdehyde 
(malondialdehyde, MDA) (1,7). MDA has been shown to react rapidly at amino group of 
amino acids and nucleobases such as adenine and cytosine, causing important mutations (8,9). 
This chemical behavior is a concern since both acidic and basic conditions are encountered 
during the dodecamer synthesis based on the solid-phase method by 2-
cyanoethylphosphoramidite chemistry (10). Several works have described improved 
conditions for oligonucleotide synthesis. Some of them substitute the more common 5’-
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hydroxyl protector group employed in the dodecamer synthesis, 4,4’-dimethoxytrityl (DMT), 
by a more acid labile group such as 9-phenylxanthene or pixyl group (11) and / or modify the 
basic treatment for the cleavage of the dodecamers from the supports (12). 
The work described here is divided into two parts. First, the synthesis of a self-
complementary dodecamer containing the K nucleoside, 5’CGTACGKGTACG3’, is 
described. For this, and due to the 2-pyrimidinone basic catalyzed hydrolysis previously 
described, two different treatments for the cleavage of the dodecamer from the supports were 
evaluated. The objective of the second part is to characterize the protonation equilibria of the 
K nucleoside and of the dodecamer at 37 ºC and 150 mM ionic strength. For this purpose, 
acid-base titrations were carried out and monitored by molecular absorption, fluorescence and 
circular dichroism (CD) spectroscopies. Melting experiments at different pH values were also 
carried out to check the validity of the concentration profiles proposed for the dodecamer.  
Kinetics studies of the K nucleoside and of the dodecamer at several pH values were also 
carried out to evaluate the acid and base catalyzed hydrolysis of 2-pyrimidinone residues.  
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EXPERIMENTAL SECTION 
Reagents and solutions 
Synthesis: HPLC grade solvents were from Merck (Germany). Standard 2-cyanoethyl 
phosphoramidites were obtained from Cruachem Ltd. (United Kingdom) and dry solvents 
employed in dodecamer synthesis from SDS (France). Analytical TLC was run on aluminum 
sheets coated with silica gel 60 F254 from Merck (Germany). Column chromatography was 
performed on silica gel 60 Å from SDS (France). The rest of reagents were purchased from 
Aldrich (USA) and Fluka (Switzerland). 2’-Deoxyzebularine was prepared as described in 
Barchi et. al work (2). 
 Analytical studies: samples were prepared in Ultrapure water (Millipore, USA) with the 
appropriate buffer compounds: sodium monohydrogenphosphate, potassium 
dihydrogenphosphate, NaOH, acetic acid, sodium acetate, hydrochloric acid. NaCl was added 
to adjust the ionic strength to 150 mM. Reagents were analytical reagent grade and were from 
Panreac (Spain), Probus (Spain) and Merck (Germany). 
 
Synthesis 
Synthesis of 5’-O-DMT-2’-deoxyzebularine: 2’-Deoxyzebularine (2) (294 mg, 1.38 mmol) 
was dried after three successive evaporations of anhydrous pyridine. The residue was 
dissolved in 3 ml of pyridine and treated with 610 mg (1.79 mmol) of 4,4’-dimethoxytrityl 
chloride. After 3h of magnetic stirring at room temperature 1 ml of methanol was added to 
stop the reaction. The yellow solution obtained was evaporated to eliminate the solvents. The 
oily residue was dissolved in 20 ml of DCM and the solution washed twice in 5% NaHCO3 
and saturated NaCl. The organic phase was dried (Na2SO4) and concentrated to dryness. The 
residue was purified by column chromatography on silica gel packed with 1% pyridine / 
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DCM and eluted with a 0 - 8% methanol gradient in DCM. The collected fractions containing 
the pure product were concentrated to dryness to obtain a white foam. Yield 51%, TLC (7% 
methanol / DCM) Rf= 0.34. 1H NMR (CDCl3) δ(ppm): 8.5 (m, 2H, H6,H4), 7.2 -7.4 (9H, 
phenyl DMT), 6.8 (4H, phenyl DMT), 6.2 (t, 1H, H1’), 6.0 (m, 1H, H5), 4.5 (m, 1H, H3’), 4.1 
(m, 1H, H4’), 3.8 (s, 6H, -OCH3(DMT)), 3.5(m, 2H, H5’), 2.8 -2.35 (m, 2H, H2’). 13C NMR 
(CDCl3) δ(ppm): 41.9 (C2’), 55.2 (CH3-O DMT), 61.8 (C5’), 72.3 (C3’), 86.5 (C q DMT), 
87.0 (C4’), 87.5 (C1’), 113.3 – 144.0 (C DMT), 156.2 (C6), 158.6 (C2), 165.5 (C4). 
Synthesis of 5’-O-DMT-2’-deoxyzebularine-3’-O-2-cyanoethyl-N,N-
diisopropylphosphoramidite: 5’-O-DMT-2’-deoxyzebularine (360 mg, 0.7 mmol) was 
dissolved in 5 ml of anhydrous DCM and 0.50 ml (2.8 mmol) of N-ethyldiisopropylamine 
were added. The reaction mixture was cooled by ice, and 0.20 ml (0.91 mmol) of 2-
cyanoethyl N,N-diisopropyl-chlorophosphoramidite was added dropwise with a syringe. After 
the addition the mixture was allowed to reach room temperature. After 30 min of magnetic 
stirring, the progress of the reaction was checked by TLC (AcOEt / DCM / Et3N (45:45:10). 
The reaction was judged completed, solvents were evaporated and the oily residue was 
dissolved in 30 ml of ethyl acetate and 1.5 ml of Et3N. The solution was washed twice with 
5% NaHCO3 and saturated NaCl. The organic phase was dried (Na2SO4) and concentrated to 
dryness. The residue was purified by column chromatography on silica gel packed with a 
AcOEt / DCM / Et3N (45:45:10) solution and eluted with AcOEt / DCM (1:1). The collected 
fractions containing the pure product were concentrated to dryness to obtain a white foam. 
Yield 71%, TLC (AcOEt / DCM / Et3N (45:45:10)) Rf= 0.60. 1H NMR (CDCl3) δ(ppm): 8.5 
(m, 2H, H6,H4), 8.46 – 8.39 (m,4H, 2-cyanoethyl), 7.2 -7.4 (9H, phenyl DMT), 6.8 (4H, 
phenyl DMT), 6.2 (t, 1H, H1’), 6.0 (m, 1H, H5), 4.5 (m, 1H, H3’), 4.1 (m, 1H, H4’), 3.8 (s, 
6H, -OCH3(DMT)), 3.4(m, 2H, H5’), 2.65 -2.43 (m, 2H, H2’), 1.0 – 1.3 (14H, diisopropyl). 
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31P NMR (CDCl3, and 85% H3PO4 as external reference. δ(ppm): 149.5 and 150.0 (two 
diasteroisomers). 
Synthesis of 5’CGTACGKGTACG3’ dodecamer: The dodecamer was prepared in 1 µmol 
scale on an Applied Biosystems 392 automatic DNA synthesizer using commercially 
available 2-cyanoethyl phosphoramidites of the natural bases (Abzl, Cbzl, T, Gdmf) and the 5’-
O-DMT-2’-deoxyzebularine-3’-O-2-cyanoethyl-N,N-diisopropylphosphoramidite previously 
synthesized. The last DMT group at the 5’ end was not removed to facilitate purification. 
Removal of base (dmf on N2-dG and bzl on N6-dA and N4-dC) and phosphate protecting 
groups and cleavage from the LCAA-CPG support was evaluated with two treatments using 
concentrated ammonia : 1) at room temperature overnight and 2) at 55 °C for 30 min. 
Ammonia solutions were filtrated, centrifuged, concentrated to dryness and dissolved in 
Ultrapure water (Millipore). Dodecamer was purified by reverse phase HPLC. The major 
peak was collected and analyzed by MS. (The collected fractions of pure product were 
concentrated by liophilization. Yield: 83 OD260 (from 5 synthesis of 1µmol), MS (MALDI-
TOF): m/z 3645.42 [M+Na+], (expected m/z 3646 [M+Na+]). 
 
Procedure 
The experimental set-up used for spectroscopically monitored acid-base titrations has already 
been described elsewhere (13,14). Melting experiments were carried out at 1 oC increments 
with a temperature ramp of 0.5 oC / minute and monitored either simultaneously by molecular 
absorption and CD, or individually by fluorescence. At each temperature, a complete 
spectrum was recorded. Each sample was heated at 65 oC for 5 minutes and allowed to 
equilibrate at the starting temperature for 30 minutes before the melting experiment was 
started. After each experiment, the sample was cooled to starting temperature and the final 
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spectrum was compared to the initial one in order to confirm the reversibility of the process. 
Kinetics experiments were carried out at 37 oC and monitored by molecular absorption and 
fluorescence. The processes were considered finished when no more spectral changes were 
observed. 
 
Apparatus 
Synthesis: HPLC and mass spectrometry were used for the dodecamer purification and 
characterization. HPLC was performed on a Shimadzu instrument as follows: solvent A was 
0.1M TEAA / ACN (95:5) and solvent B was 0.1M TEAA / ACN (3:7); column: a 
polystyrene column, Hamilton PRP-1, 250 x 10 mm; flow rate: 3ml/min. A 0 – 80 % B linear 
gradient in 20 min and detection at 260 nm was applied for DMT-oligonucleotides and, a 0 – 
50 % B linear gradient in 20 min and detection at 260 nm was applied for oligonucleotides 
after the removal of the DMT group.  MALDI-TOF mass spectrometry measurements were 
performed in a Voyager DE-RP Applied Biosystems instrument using 3-hydroxypicolinic 
acid as the matrix. 
Analytical studies: Molecular absorption spectra were recorded on a Perkin-Elmer lambda-19 
spectrophotometer. Fluorescence spectra were recorded on an Aminco-Bowman series 2 
spectrofluorimeter (λexc: 303 nm, λem: 325 - 500 nm). These instruments were located in the 
same laboratory, which enabled the simultaneous recording of molecular absorption and 
fluorescence spectra. CD spectra were recorded on a Jasco J-720 spectropolarimeter equipped 
with Neslab RET-110 temperature control unit. This spectropolarimeter allowed the 
calculation of molecular absorption spectra by means of the mathematical treatment of the 
output signal included in the software, allowing the simultaneous recording of molecular 
absorption and CD spectra. Hellma quartz cuvettes (path length of 1.0 cm) were used. pH 
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measurements were performed with an Orion model 701A pH meter (precision of  ± 0.1 mV) 
and a combined Ross pH electrode (Orion 9103).  
 
DATA TREATMENT 
The molecular absorption, fluorescence or CD spectra recorded along each experiment were 
collected in a table or matrix D. The dimensions of D were Nr rows x Nm columns, where Nr 
were the spectra recorded at successive pH, temperature or time values and Nm was the 
number of wavelengths measured in every spectra (Scheme 1a). Spectroscopic data arranged 
in matrices were analyzed to obtain information about the thermodynamic behavior of the 
system. Hence, for an acid-base titration, the information to be recovered consisted on the 
number of acid-base species present along the titration, their concentration profiles and the 
pure spectrum for each one of those species. For melting experiments, the information 
consisted of the number of conformations, their concentration profiles and the pure spectrum 
for each one of them. Finally, for kinetics experiments, the information consisted of the 
number of species, their kinetics profiles, and the pure spectra. Mathematically, the 
experimental data model can be written as: 
D = C ST + E                               (equation 1) 
where C, ST and E are, respectively, data matrices containing the concentration profiles, the 
pure spectra and the residual noise not explained by the species or conformations in C and ST. 
Two different approaches have been used to decompose the experimental data matrix D 
according to equation 1: the hard-modeling-based EQUISPEC procedure (15) and the soft-
modeling-based Multivariate Curve Resolution based on Alternating Least Squares procedure 
(16). EQUISPEC is based on the postulation of an initial chemical model defined by: (1) the 
stoichiometries of the proposed species, (2) by approximate values of their equilibrium 
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constants and (3) on the compliance of the mass-action law. This procedure is especially 
useful when applied to the study of chemical equilibria of monomers or oligomers, where the 
mass-action law is fulfilled and no secondary effects related to large polymeric structures, like 
polyelectrolytic or polyfunctional effects or conformational changes are present. On the other 
hand, for large polymeric systems or when analyzing data from melting experiments, 
application of hard-modeling procedures is rather difficult or even impossible since it is 
difficult to postulate a physical and chemical model describing the observed data variance. In 
these cases, however, data analysis is still possible by applying soft-modeling factor analysis-
based methods because these do not require the previous postulation of a physical or chemical 
model. Multivariate Curve Resolution based on Alternating Least Squares (MCR-ALS) has 
been widely applied for the study of acid-base and conformational transitions of 
polynucleotides (13, 14, 17-19). The mathematical bases of EQUISPEC and MCR-ALS have 
been previously described elsewhere and not given here for the sake of brevity (16, 19, 20). 
Equation 1 can be applied to the analysis of a single data matrix or to the simultaneous 
analysis of several data matrices (14, 17). In this work, a simultaneous analysis was applied 
several times (Scheme 1b - 1d). To carry out such an analysis, an augmented data matrix is 
first built up by joining several data matrices before applying equation 1. These data matrices 
correspond either to spectra recorded with different instrumental techniques along a single 
experiment (row-wise augmented data matrix), to spectra recorded with a single instrumental 
technique in different experiments (column-wise augmented data matrix), or to a combination 
of the two previous data matrix arrangements, i.e, to spectra recorded with different 
instrumental techniques throughout a single experiment combined with spectra recorded in 
different experiments (row- and column-wise augmented data matrix). In all these cases, this 
simultaneous analysis was shown to improve dramatically the reliability of the obtained 
results (16, 17), solving difficulties appearing in the analysis of a single data matrix such as 
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rank deficiency (17, 20-21). This is a difficulty commonly present in chemical reaction based 
systems when the number of independent reactions plus one is lower than the number of 
chemical species involved in these reactions (22). This fact produces that concentration 
profiles obtained will not be linearly independent and the number of detected species will be 
less than the number of species really present in the system. Deeper investigation of the 
analysis of augmented data matrices have also been published recently (14, 17, 23). 
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RESULTS AND DISCUSSION 
Dodecamer synthesis 
Dodecamer was prepared using solid-phase 2-cyanoethylphosphoramidite chemistry (10). The 
required synthon to incorporate 2’-deoxyzebularine into oligonucleotides was prepared 
starting from the corresponding nucleoside that was synthesized as previously described (2). 
The DMT group was selected for protection of the 5’-end. Reaction of 2’-deoxyzebularine 
with DMT chloride in pyridine gave the desired DMT-nucleoside that was reacted with 2-
cyanoethyl-N,N-diisopropylchlorophosphine to yield the desired phosphoramidite. The 2’-
deoxyzebularine phosphoramidite was purified by silica gel chromatography and 
characterized by proton and phosphorous NMR. Solid phase synthesis study using this 
phosphoramidite revealed a step-coupling yield similar to standard phosphoramidites (>98%). 
On the other hand, to investigate the dodecamer stability under the basic treatment of cleavage 
from the support, LCAA-CPG, two syntheses at small scale were carried out. The last DMT 
was not removed to facilitate purification using reversed phase HPLC. One of the 
oligonucleotides was treated with concentrated ammonia at 55 °C for 30 min and another with 
concentrated ammonia at room temperature overnight. In both cases (Figure 1a) and in the 
area corresponding to DMT-containing oligonucleotides a major eluting peak (at 12.18 min) 
was found with a smaller peak near the major peak (at 11.62 min). From both syntheses these 
two eluting peaks were collected and, after the DMT group was removed, analyzed by means 
of HPLC. Chromatograms showed a single eluting peak from the collected previously eluted 
peak at 12.18 min (Figure 1b) and a still mixture of the major and minor components from the 
collected previously eluted peak at 11.62 min (Figure 1c). Molecular absorption analyses of 
major component showed an absorption band maximum at 260 nm characteristic of the four 
natural nucleosides absorption with a shoulder at 303 nm characteristic of the 2’-
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deoxyzebularine absorption. Mass-spectrometry analysis of this material confirmed the mass 
expected for the dodecamer (m/z 3645.42 [M+Na+]. Mass-spectrometry analysis of the minor 
component showed a m/z 3614.28 [M+Na+] peak not in agreement with the dodecamer 
structure without the 2-pyrimidinone ring (m/z expected for dodecamer without 2-
pyrimidinone base 3552 [M+Na+]), indicating no abasic site formation (6) under the 
experimental conditions of the acidic 5’-DMT group deprotection steps. This material could 
be an impurity or a degradation product from the basic catalyzed hydrolysis of 2’-
deoxyzebularine produced by basic cleavage from the LCAA-CPG support. It was noticeable 
from the chromatograms that the area of the minor component was higher after treatment with 
concentrated ammonia at room temperature overnight than after 30 min at 50 ºC. Moreover, 
HPLC analysis showed some small eluting peaks at higher retention times, and these were 
assigned to sequences still carrying some protecting groups. These small peaks did not appear 
in the sample treated with a 30 min treatment at 50 ºC. From these results, all syntheses were 
finished with a concentrated ammonia treatment at 50 °C for 30 min. 
 
Protonation studies 
Acid-base titrations of K nucleoside monitored using molecular absorption (Figure 2a, 
corresponding to data matrix Dabs) and fluorescence (Figure 2b, matrix Dfl) were carried out at 
37 oC and 0.15 M ionic strength to determine the pKa value of the nucleoside and to 
characterize the fluorescence signal before its incorporation to the oligonucleotide. The main 
trends observed in molecular absorption spectra upon protonation were a red shift of the 
maximum from 303 to 308 nm and a slight decrease of intensity. Fluorescence spectra 
obtained at neutral pH values showed a double band with maxima at 360 and 382 nm. Upon 
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protonation the intensity of fluorescence increased dramatically and finally a maximum at 357 
nm and a shoulder over 380 nm were measured. 
Matrices Dabs and Dfl were grouped in a row-wise augmented data matrix with dimensions 
number of rows, Nr, = 18 pH values and number of columns, Nm, = 297 wavelengths (i.e., 
121 wavelengths measured in molecular absorption from 240 to 360 nm and 176 wavelengths 
measured in fluorescence measurements from 325 to 500 nm). This augmented matrix is 
given in Scheme 1b and written in a shorter way (using Matlab notation (23)) as [Dabs, Dfl]. 
The analysis of this augmented matrix by EQUISPEC (14) according to equation 1 allowed 
the calculation of the pKa value for the N3 position at the experimental conditions (3.13 ± 
0.09). This value is rather close to the pKa value determined for 2-pyrimidinone base at 
different experimental conditions of 20 ºC (pKa = 2.5, (24)). Figure 2c-d show the calculated 
pure spectra SabsT and SflT, which agree with the experimental observations, as commented on 
above. Figure 2e shows the resolved concentration profiles C which shows that at neutral pH 
the K nucleoside is fully deprotonated. 
Once the protonation equilibrium of the K nucleoside was studied, a similar procedure was 
applied to study the acid-base behavior of the dodecamer. From basic to neutral pH the 
maximum of the molecular absorption spectra shifted from 261 to 256 nm (Figure 3a, matrix 
Dabs). From neutral to acidic pH, a slight shift from 256 to 261 nm and a hyperchromic effect 
was also observed, a fact that could reflect the base stacking disruption when protonation 
takes place. CD spectra recorded at basic pH values showed a negative band at 240 nm 
(Figure 3b, matrix DCD). Upon protonation the intensity increased and the position shifted to 
250 nm, which would reflect a B-helical form at neutral pH values. At more acidic pH values, 
the CD negative band shifted to 244 nm, indicating the partial disruption of the B-helical form 
due to the protonation of cytosine and adenine bases. At pH values below 2, the complete 
breaking of the double-stranded structure was reflected in the low signal-to-noise ratio 
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observed. Finally, fluorescence spectra for the pH range 7.7 – 2.2 (Figure 3c, matrix Dfl) 
reflect a dramatic change in the fluorescence of the fully protonated dodecamer species due to 
the protonation of the K nucleoside. No precipitate was observed along the titrations either at 
acidic or basic pH values. 
As molecular absorption and CD data were simultaneously recorded, an augmented [Dabs, 
DCD] matrix was built up (Scheme 1b). On the other hand, as fluorescence data were obtained 
in an independent experiment, Dfl matrix had to be analyzed individually (Scheme 1a). In all 
the cases, data were analyzed by EQUISPEC considering the presence of three, four or five 
acid-base species. The reliability on those models was analyzed according to the final results 
obtained with each one of them, i.e., according to the chemical sense of the calculated pKa 
values, concentration profiles, the pure spectra and to the residual magnitude of the variance 
not explained by each model. The system including four species, i.e., three pKa values, was 
finally considered to be the most chemically meaningful. For this system, the calculated pKa 
values were: 9.60 ± 0.07, 4.46 ± 0.16 and 2.87 ± 0.19. Figure 3d-f show, respectively, the 
pure molecular absorption spectra SabsT, the pure CD spectra SCDT, and the pure fluorescence 
spectra SflT for each one of the four proposed species. Figure 3g shows the corresponding 
calculated concentration profiles C. The explanation for these species is as follows: at pH 
values around 10, the dodecamer shows all nitrogenated bases deprotonated, with neutral 
cytosine, adenine and 2-pyrimidinone but with anionic thymine and guanine at N3 (N(3)-T) 
and N1 (N(1)-G) positions, respectively. At neutral pH, the protonation of N(3)-T and N(1)-G 
shows the dodecamer with neutral bases. At pH around 3.5, protonation of adenine at N1 and 
cytosine at N3 is observed. Finally, at lower pH values, the dodecamer shows protonation of 
2-pyrimidinone at N3 and guanine at N7. Concentration profiles C show that double-stranded 
B-dodecamer is only present as a major species in a very narrow region around pH 7. The 
calculated pKa values for the four natural bases into the dodecamer are quite similar to the 
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pKa values found in literature for the free bases (25). As expected, the calculated pKa value 
for 2-pyrimidinone when incorporated into the dodecamer is slightly lower than that 
calculated for the K nucleoside, i.e., protonation is a little more difficult when the base forms 
hydrogen bonds with guanine bases in the dodecamer.  
The calculated pure spectra (Figure 3d-f) agree well with the observed experimental trends. 
The protonation of cytosine and adenine bases is more clearly reflected in the calculated 
molecular absorption and CD pure spectra (SabsT, SCDT) than in the calculated fluorescence 
pure spectra (SflT). SflT for the neutral (labeled as 3) and intermediate (labeled as 2) species 
are very similar. However, the protonation of the 2-pyrimidinone base at the K nucleoside 
(see above) is clearly reflected in the dramatic increase of fluorescence for the pure spectrum 
of the fully protonated species (labeled as 1).  
Cooperative effects related to the polymeric structure of polynucleotides can usually be 
denoted in protonation equilibria by the presence of pronounced slopes in species distribution 
concentration profiles (13, 26). When these effects are present, the acid-base equilibria for 
each protonation site in the polynucleotide cannot be characterized by a single constant pKa 
value. However, in the present case, from the slope of the acid-base concentration profiles C 
(Figure 3g), no cooperative behavior related to the polymeric structure could be deduced, i.e. 
the pKa value for each one of the nitrogenated bases was not affected by the protonation / 
deprotonation of neighboring bases. This conclusion is reinforced by the results obtained 
when applying EQUISPEC, which uses a hard-modeling approach, for the study of 
protonation equilibria. From the results obtained in this previous research (13, 14, 18), hard-
modeling methods can be used without problems for the study of protonation equilibria for 
oligonucleotides like dodecamers.  
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Melting studies 
Melting experiments at pH values 3.1, 3.9 and 6.7 were carried out to confirm the conclusions 
derived from the previous protonation studies. The reversibility of the unfolding processes at 
pH 3.1 and 3.9 were checked by recording one spectrum after a long stabilization time at the 
initial temperature. Reversibility of the melting process at pH 6.7 was studied in detail with an 
annealing experiment monitored by molecular absorption and CD. While the melting 
experiments at pH 3.9 and 6.7 were reversible, melting at pH 3.1 was irreversible, probably 
because of the labile behavior of 2-pyrimidinone residues in acidic medium and high 
temperature. Kinetic experiments were carried out to confirm this point (see below). Due to 
the irreversibility of the melting process at pH 3.1, experimental data were not analyzed in 
this case. At pH 6.7, the loss of the initial structure is reflected in: a) the increase of 
absorbance with a shoulder formation over 270 nm; b) the blue shift and decrease of the 
intensity of the CD band at 250 nm, typical of B-DNA; c) the fluorescence intensity decrease 
with the differentiation of the band over 350 nm, characteristic of the K nucleoside. 
Spectroscopic data were analyzed by means of the soft-modeling procedure MCR-ALS. For 
this purpose molecular absorption and CD spectra recorded along melting experiments at pH 
3.9 and 6.7 and annealing experiment at pH 6.7 were arranged in a row-wise augmented data 
matrix together with the molecular absorption and the CD pure spectra resolved by 
EQUISPEC from the previous protonation studies of the dodecamer (Figure 3d-e). The 
augmented matrix used in these analyses is given in Scheme 1c and written in a shorter way 
as [[STabs,STCD]acid-base; [Dabs, DCD]melting pH 3.9; [Dabs, DCD]melting pH 6.7; [Dabs, DCD]annealing pH 6.7 ]. 
The dimensions of this augmented matrix are Nr = 95 (3 estimated EQUISPEC spectra plus 
28 spectra measured in the melting experiment at pH 3.9 plus 31 spectra measured in the 
melting experiment at pH 6.7 plus 33 spectra measured in the annealing experiment at pH 6.7) 
and Nm = 244 (122 wavelengths recorded in every technique from 235 to 356 nm). 
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Simultaneous MCR-ALS analysis of all these data sets resolved four components in the 
temperature range under study with the molecular absorption and CD pure spectra, SabsT, SCDT 
(Figure 4a and 4b). Two of the calculated pure spectra of these four components were 
coincident with the pure spectra previously obtained for the dodecamer with neutral 
nucleobases and for the dodecamer with protonated cytosine and adenine bases. The other two 
components were assigned to unfolded random-coil conformations. Calculated concentration 
profiles for the melting experiment at pH 3.9 and pH 6.7 are shown in Figure 4d-e, 
respectively. Calculated concentration profiles for the annealing experiment at pH 6.7 are 
shown in Figure 4f. Figure 4d shows the presence at initial temperature values of a mixture of 
the dodecamer with deprotonated nucleobases and, as a main component, of the dodecamer 
with protonated adenine and cytosine. This agrees with the protonation species previously 
obtained at this pH (Figure 3g). When temperature is increased, the transition of these two 
species to random coil-conformations is observed. From Figure 4d, a Tm value = 42 oC was 
estimated from the crossing point of the two resolved concentration profiles (curves 2 and 5) 
for the dodecamer with protonated adenine and cytosine. A Tm value = 44 oC was determined 
from the crossing point of resolved concentration profiles (curves 3 and 6) for the 
deprotonated dodecamer at pH 3.9. Calculated concentration profiles obtained for the melting 
experiment at pH 6.7 (Figure 4e) showed the transition between the initial double-stranded 
conformation with all nucleobases deprotonated (B-form) and the final random-coil 
conformation. For this melting process, a value for Tm = 50.5 oC from the resolved 
concentration profiles C. For the annealing process at pH 6.7, a value for Tm = 50.9 oC was 
determined. From the lack of significant differences in the calculated Tm values for the 
melting and the annealing experiments, it was concluded the reversibility of the process at pH 
6.7.  
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Fluorescence data obtained in the melting experiment at pH 6.7 were analyzed individually 
(Scheme 1a). In Figure 4c the resolved fluorescence species normalized spectra SflT are given. 
The value of Tm = 50.3 oC was determined from the resolved concentration profiles C. The 
concentration profiles obtained from the fluorescence experiment at pH 6.7 were not plotted 
because they were very similar to Figure 4d-f. To study the possible existence of non-
hyperchromic transitions assigned to intermediate hairpin-shaped structures (27), MCR-ALS 
analysis of experimental CD data was also performed. No intermediate structures were 
detected in this case. 
From the results obtained, it was deduced that Tm values increase with the pH. This fact was 
related to the relatively more stable double-stranded structure at neutral pH values. Upon 
protonation, a disruption of the structure was observed and, consequently, the corresponding 
Tm value decreased. Tm values estimated for dodecamer at pH 3.9 and 6.7 were quite 
different, which confirmed that one species was predominant in each region, as depicted in 
Figure 3g. Simultaneous analysis of melting experiments augmented with estimated pure 
spectra obtained in protonation studies allowed the resolution of the melting process of the 
mixture of species at pH 3.9 and confirmed that at pH 6.7 only one species was predominant. 
Tm values calculated from molecular absorption-CD or fluorescence monitored melting 
experiments at pH 6.7 showed good agreement, indicating that both approaches gave a similar 
description of the melting process for the dodecamer sequence. Whereas the melting 
experiment monitored by molecular absorption showed the global perturbation of the duplex, 
the same experiment monitored by fluorescence showed local perturbations in the 
neighborhood of the fluorophore (in this case, the 2-pyrimidinone base). Because Tm values 
obtained from molecular absorption and fluorescence experiments were quite similar, it was 
concluded that the global duplex disruption is coincident with the local perturbation of the 
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helix around of the K·G base pair. This would be related to a similar strength of the K·G base 
pair in relation to the global duplex stability. 
 
Kinetic studies 
Due to the acidic and basic labile behavior of the residues containing the 2-pyrimidinone 
base, it was decided to study the stability of the K nucleoside and of the dodecamer as a 
function of time during the acid-base studies. Hence, kinetics experiments of the K-nucleoside 
at 37 ºC and at pH values 2.1, 3.1, 4.1, 9.2 and 11.9 were carried out monitored by molecular 
absorption and fluorescence. Finally, the labile behavior of the K nucleoside when 
incorporated into the dodecamer was studied at pH 3.1 at 37 ºC. 
The molecular absorption spectra of the K nucleoside at pH 2.1, 3.1 and 4.1 showed a 
progressive decrease of absorbance with a blue shift of the maximum (from 310 to 307 nm for 
experiment at pH 2.1, from 304 to 301 nm for experiment at pH 3.1 and from 303 to 300 nm 
for experiment at pH 4.1) along time. Individual analysis of these experiments by means of 
MCR-ALS revealed the presence of only two components at each pH value, which were 
assigned to the K nucleoside and to a mixture of the ribose ring and of the 2-pyrimidinone 
base, obtained after a N-glycosyl bond cleavage without base structure breakage (5). 
However, from the concentration profile obtained along acid - base experiments (Figure 2e), 
it was clear that at the beginning of the kinetic experiment at pH 3.1 there should be a mixture 
(1:1) of protonated and deprotonated K nucleoside, being both hydrolyzed. This fact produces 
a rank deficiency problem (19), as has been previously shown in melting experiments (see 
above) and in previous works (13, 17, 18). This problem can be solved by MCR-ALS 
simultaneous analysis of the matrix obtained in different kinetic experiments at pH 2.1, 3.1 
and 4.1 together with the molecular absorption pure spectra resolved by EQUISPEC in the 
previous protonation studies for protonated and deprotonated K nucleoside (Figure 2c). The 
  20
augmented matrix was built up according to Scheme 1d and written in a shorter way as 
[STabsacid-base; Dabskinetic pH 2.1; Dabskinetic pH 3.1; Dabskinetic  pH 4.1 ]. The dimensions of this augmented 
matrix are Nr = 363 (2 estimated EQUISPEC spectra, plus 67 spectra measured in the kinetic 
experiment at pH 2.1, plus 110 spectra measured in the kinetic experiment at pH 3.1, plus 184 
spectra measured in the kinetic experiment at pH 4.1) and Nm = 102 (102 wavelengths 
recorded from 259 to 360 nm). The analysis revealed the presence of four components with 
the molecular absorption pure spectra shown in Figure 5a. Calculated molecular absorption 
pure spectra of two of these four components were practically identical to the pure spectra 
obtained for protonated and deprotonated K nucleoside (Figure 2c). The other two 
components were assigned to the species resulting from the hydrolysis process: a mixture of a 
ribose ring with a protonated nucleobase and a mixture of ribose ring and deprotonated 
nucleobase. Calculated concentration profiles obtained for the kinetic experiments at pH 2.1 
and 4.1 (Figure 5b and 5d) showed the N-glycosyl bond cleavage with time for the protonated 
and deprotonated K nucleoside, respectively. From the crossing points of curves in these 
concentration profiles, it was observed that 50 % of the glycosyl bond hydrolysis took place 
after 0.23 and 6.5 hours, respectively. Calculated concentration profiles obtained for the 
kinetic experiment at pH 3.1 (Figure 5c) showed the glycosyl bond hydrolysis for a mixture of 
the protonated and of the deprotonated K nucleoside giving the corresponding mixture of 
ribose ring and protonated and deprotonated nucleobase. The resulting nucleobases obtained 
in these hydrolysis processes were also in acid-base equilibrium, which at this pH value is 
shifted to the deprotonated nucleobase (pKa 2.5 (24)). This equilibrium could explain the 
apparent absence, at the beginning of this experiment, of the expected 1:1 ratio for the 
mixture of deprotonated and protonated K nucleoside. From the crossing point of curves in 
concentration profile given in Figure 5c, it was observed that 50% of the depyrimidination 
process took place after 0.4 (curves 1’ and 3’) and 0.68 (curves 2’ and 4’) hours for 
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protonated and deprotonated K nucleoside, respectively. Concentration profiles (curve 1’) 
given in Figure 5b-c for the hydrolysis of protonated K nucleoside at pH 2.1 and 3.1, 
respectively, were fitted to exponential curves and the obtained rate constant values were 1.35 
x 10-3 and 4.82 x 10-4 s-1. In the same way, concentration profiles (curve 2’) given in Figure 
5c-d for the hydrolysis of deprotonated K nucleoside at pH 3.1 and 4.1, respectively, were 
fitted to exponential curves and the obtained rate constant values 3.41 x 10-4 and 3.13 x 10-5 s-
1 were obtained. A rate value of 1.05 x 10-4 s-1 was previously reported (5) for the hydrolysis 
of K nucleoside at pH 3.0 and room temperature. This value agrees well with the values given 
in this work at pH 3.1, although in this previous work was not considered the acid - base 
equilibrium of K nucleoside. As expected, the glycosyl bond hydrolysis was pH dependent 
and followed pseudo first-order kinetics which can be expressed for the hydrolysis of 
protonated and deprotonated 2-pyrimidinone respectively, as: 
d[dKH] / dt = -k1’ [dKH]n     and   d[dK] / dt = -k2’ [dK]n                                        (equation 2) 
where k1’ and k2’are pseudoconstants which depends on the concentration of proton (i.e. 
depending on pH). 
Molecular absorption spectra recorded in a kinetic experiment at pH 9.2 (72 hours) showed 
few changes, a finding which was related to the higher stability of the glycosyl bond at this 
pH value. It was only observed a small absorbance change at 270 nm. Whereas these changes 
at pH 9.2 were rather small, noticeable changes were however observed at pH 11.9. MCR-
ALS analysis determined the presence of three main components along the kinetics at this pH 
11.9. Figure 6 shows pure spectra SabsT and concentration profiles C. It was observed that the 
third species is the only species after 75 hours of reaction. This species was assigned to the 
breakage of the 2-pyrimidinone ring. The second species was related to the intermediate 
species formed during the nucleophilic attack by hydroxyl anions over the 2-pyrimidinone 
positions C5=C6. Finally, the first species is the initial K nucleoside (1, 9). 
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Kinetics of the dodecamer sample was also studied at pH 3.1 for 24 hours. During this time, 
no spectral changes were observed which could be related to the hydrolytic cleavage of the 
glycosyl bond in the dodecamer. From the comparison of these results with those obtained for 
the K nucleoside in the same experimental conditions, it was concluded that the stability of 
the K nucleoside increased dramatically upon incorporation into the dodecamer. Moreover, 
the observed stability was still enough to carry out the protonation studies satisfactorily 
without considering the degradation of the dodecamer. Finally, the non-reversibility observed 
for the dodecamer unfolding experiment at pH 3.1 probably showed a temperature 
dependence of depyrimidination process of the K nucleoside. 
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FIGURE CAPTIONS 
Scheme 1. Different arrangements of matrices used in data analysis. (a) Analysis of a single matrix 
containing molecular absorption, CD or fluorescence spectral data recorded along an acid-base, 
thermal or kinetic experiment. Simultaneous analysis of a set of correlated data matrices by (b) row-
wise matrix augmentation of a molecular absorption and CD (or fluorescence) acid-base study, ([Dabs , 
DCD (fl)]) (c) row- and column-wise matrix augmentation of a molecular absorption and CD thermal 
study together with the pure spectra resolved by EQUISPEC in the previous protonation studies, 
([[STabs , STCD]acid-base; [Dabs , DCD]pH 1;…; [Dabs , DCD]pH n]). (d) column-wise matrix augmentation of a 
molecular absorption kinetic study together with the pure spectra resolved by EQUISPEC in previous 
protonation studies, ([ST absacid-base; Dabskinetic 1;…; Dabskinetic n]). 
D: data matrix; C: concentration profiles matrix, ST pure spectra matrix; E: residual matrix; N: active 
spectroscopic species, conformations or degradation products. 
Figure 1. (a) Reversed-phase HPLC analysis from the 5’CGTACGKGTACG3’ synthesis ended with 
the last 5’-DMT protector group, with a 0 – 80 % B linear gradient in 20 min. (b) Reversed-phase 
HPLC analysis after extraction of the 5’-DMT protector group from the collected peak eluted in (a) at 
12.18 min, with a 0 – 50 % B linear gradient in 20 min. (c) Reversed-phase HPLC analysis after 
extraction of the 5’-DMT protector group from the collected peak eluted in (a) at 11.62 min, with a 0 – 
50 % B linear gradient in 20 min. Analysis carried out with a polystyrene column Hamilton PRP-1, 250 
x 10 mm; flow rate: 3ml/min; solvent A was 0.1M triethylammonium acetate/acetonitrile (95:5) and 
solvent B was 0.1M triethylammonium acetate/acetonitrile (3:7). 
Figure 2. Protonation studies of K nucleoside. (a) Experimental molecular absorption spectra 
recorded along the pH range 2.1 – 7.4, Dabs. (b) Experimental fluorescence spectra recorded in the 
same pH range, Dfl. (c) Pure molecular absorption spectra for the acid-base species calculated by 
EQUISPEC, SabsT. (d) Pure fluorescence spectra, SflT. (e) Concentration profile, C. Dashed line (1’): 
protonated base. Continuous line (2’): deprotonated base. The arrows indicate the pH values where K 
nucleoside kinetics experiments were carried out. 
Figure 3. Protonation studies of the 5’CGTACGKGTACG3’ dodecamer. (a) Experimental molecular 
absorption spectra recorded along the pH range 1.9 – 10.4, Dabs. (b) Experimental CD spectra 
recorded along the same pH range, DCD. (c) Experimental fluorescence spectra recorded along the pH 
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range 2.2 – 7.7 , Dfl. (d) Pure molecular absorption spectra for the acid-base species calculated by 
EQUISPEC, SabsT. (e) Pure CD spectra, SCDT. (f) Pure fluorescence spectra, SflT. (g) Concentration 
profile, C. Symbol (‘star’) indicates the pH values where melting experiments were carried out. The 
arrow indicates the pH value where dodecamer kinetics experiment was carried out.  (1) dodecamer 
with all the bases protonated; (2) dodecamer with protonated cytosine and adenine and deprotonated 
2-pyrimidinone, thymine and guanine; (3) dodecamer with neutral bases; (4) dodecamer with neutral 
cytosine, adenine and 2-pyrimidinone but with anionic thymine and guanine. 
Figure 4. MCR-ALS results of the analysis of melting experiments of 5’CGTACGKGTACG3’ 
dodecamer (a) Pure molecular absorption spectra SabsT and (b) pure CD spectra SCDT for the species 
calculated by simultaneous MCR-ALS analysis of melting at pH 3.9, melting at pH 6.7 and annealing 
at pH 6.7. (c) Pure normalized fluorescence spectra, SflT, for the melting experiment at pH 6.7 (d) 
Concentration profiles for the melting at pH 3.9. (e) Concentration profile for the melting at pH 6.7. (f) 
Concentration profile for the annealing at pH 6.7.  (2) and (3) as in Figure 3; (5) random coil 
conformation from the dodecamer with protonated adenine and cytosine and deprotonated thymine, 
guanine and 2-pyrimidinone; (6) random coil conformation obtained from the dodecamer with neutral 
nucleobases.  Preparation of solutions: 8.2 mM acetic acid, 1.93 mM sodium acetate, 150 mM NaCl, 
pH 3.9; 10 mM KH2PO4, 10 mM Na2HPO4, 149 mM NaCl: pH 6.7. 
Figure 5. Kinetics experiments of K nucleoside. (a) Pure molecular absorption spectra SabsT .(b) 
Concentration profile C at pH 2.1. (c) Concentration profile C at pH 3.1, (d) Concentration profile C at 
pH 4.1. (1’) protonated K nucleoside; (2’) deprotonated K nucleoside; (3’) mixture of ribose and 
protonated nucleobase after glycosyl bond cleavage; (4’) mixture of ribose and deprotonated K 
nucleobase after glycosyl bond cleavage. Preparation of solutions: 17.7 mM HCl, 147.8 mM NaCl, pH 
2.1; 4.7 mM HCl, 149.9 mM NaCl, pH 3.1; 8.2 mM acetic acid, 1.93 mM sodium acetate, 150 mM NaCl 
pH 4.1. 
Figure 6. Kinetics experiment of K nucleoside at pH 11.9 (18.4 mM NaOH, 135.1 mM NaCl) (a) Pure 
spectra resolved by MCR-ALS, SabsT. (b) Concentration profiles resolved by MCR-ALS, C. Inset: 
amplification of the interval 0 - 2h. Continuous line: K nucleoside. Dashed line: intermediate from the 
nucleophilic attack by hydroxyl ions over the 2-pyrimidinone positions C5=C6. Dotted line: breakage of 
the 2-pyrimidinone ring. 
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